|
PIP4K2C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.889600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.414000E-02 |
| Normal-vs-Stage2 |
4.677800E-03 |
| Normal-vs-Stage3 |
3.586600E-01 |
| Normal-vs-Stage4 |
3.501800E-01 |
| Stage1-vs-Stage2 |
1.905950E-02 |
| Stage1-vs-Stage3 |
5.354800E-01 |
| Stage1-vs-Stage4 |
7.280600E-01 |
| Stage2-vs-Stage3 |
1.469590E-02 |
| Stage2-vs-Stage4 |
4.285700E-02 |
| Stage3-vs-Stage4 |
9.051400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.568400E-02 |
| Normal-vs-AfricanAmerican |
1.465760E-01 |
| Normal-vs-Asian |
6.501800E-01 |
| Caucasian-vs-AfricanAmerican |
7.704000E-01 |
| Caucasian-vs-Asian |
3.688200E-01 |
| AfricanAmerican-vs-Asian |
3.814200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.017000E-01 |
| Normal-vs-Female |
1.845580E-02 |
| Male-vs-Female |
5.510100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.900400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.644040E-01 |
| Normal-vs-Age(61-80Yrs) |
2.175800E-02 |
| Normal-vs-Age(81-100Yrs) |
7.939400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.598200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.337800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.091800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.238200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.699400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.259000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.769200E-01 |
| Classical-VS-Follicular |
2.536000E-01 |
| Classical-VS-Other |
2.283800E-01 |
| Classical-VS-Normal |
7.081800E-02 |
| Tall-VS-Follicular |
8.708200E-01 |
| Tall-VS-Other |
1.789210E-01 |
| Tall-VS-Normal |
1.142950E-01 |
| Follicular-VS-Other |
5.076400E-02 |
| Follicular-VS-Normal |
2.749800E-02 |
| Other-VS-Normal |
5.033400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.378200E-02 |
| Normal-vs-N1 |
5.199000E-01 |
| N0-vs-N1 |
3.599900E-02 |
|
|
